GSK’s Malaria Vaccine To Be Made By Bharat Biotech For WHO
Move To Improve Access
GSK is transferring technology for the manufacture of its malaria vaccine antigen to Bharat Biotech and by 2029 will also transfer rights to supply the vaccine to WHO-approved immunization programs. The deal is expected to improve access via lower costs for such programs.
